Abstract:This study is an attempt to gain a better understanding of the physicochemical interaction between novel anticancer drugs and DNA bases. We have employed quantum chemical tools to explore the interaction of a few anticancer drugs [namely procarbazine (PR), dacarbazine (DC) and triethylenemelamine (TR)] with isolated normal (GC and AT) and mismatch (AA, CC, GG and TT) base pairs. The molecular geometries, electronic structural stability, vibrational energies, chemical reactivity and other electronic properties were studied using MP2/6-311+G**, B3LYP/6-311+G** and M05-2X/6-311+G** methods. The optimised geometries of the usual and mismatch base pairs are almost planar whereas the geometries of drug-interacting complexes deviate from planarity. The presence of steric hindrance and π-bond overlaps between C–C bonds in the complexes has distorted the planarity of the four- and five-member rings in the base pairs. Among the three drugs chosen, DC and PR bond well with normal and mismatch base pairs with large interaction energy. The electron density (ED) difference maps of the most stable GG–DC, GG–PR and GG–TR drug-interacting complexes show the information about sharing of ED and gain or loss of ED within the interacting molecules. The stabilisation energy of the charge transfer interaction between the relevant donor–acceptor orbital of GG–DC and GC–DC complexes has been found to be around 16 kcal/mol and GG–PR and GC–PR complexes has been found to be around 12 kcal/mol. But, for the GG–TR and GC–TR complexes, the stabilisation energy is found to be less than 6 kcal/mol. Moreover, the topological analysis of hydrogen bond network of DC and PR drug-interacting complexes have high electron and Laplacian density with structural stability at the bond critical points (BCPs), while compared TR drug-interacting complexes by atoms in molecules and natural bond orbital analysis. Finally, we may conclude that the drugs DC and PR are highly efficient drugs to target normal and mismatch base pair for control and inhibition of DNA replication.

Calculation of the Binding Affinity of the Anticancer Drug Daunomycin to DNA by a Statistical Mechanics Approach

Melting Profile and Temperature Dependent Binding Constant of an Anticancer Drug Daunomycin-Dna Complex

Premelting Base-Pair Opening Probability And Drug-Binding Constant Of A Daunomycin-Poly D(Gcat)Center-Dot-Poly D(Atgc) Complex

Mechanism of Daunomycin Intercalation into DNA from Enhanced Sampling Simulations

Molecular Recognition of Parallel G-quadruplex [d-(TTGGGGT)]4 Containing Tetrahymena Telomeric DNA Sequence by Anticancer Drug Daunomycin: NMR-Based Structure and Thermal Stability

Sequence specificity in DNA-drug intercalation: MD simulation and density functional theory approaches

The Adsorption-Desorption Transition of Double-Stranded DNA Interacting with an Oppositely Charged Dendrimer Induced by Multivalent Anions

Label-free Electrochemical Detection of Genetic Damage Induced by the Interaction of a Novel Potential Aminoanthraquinone-Derived Antitumor Agent with DNA Modified Electrode

Effect of Drug-Binding-induced Deformation on the Vibrational Spectrum of a DNA⋅daunomycin Complex

Structure–affinity relationships for the binding of actinomycin D to DNA

Understanding enhanced mechanical stability of DNA in the presence of intercalated anticancer drug: Implications for DNA associated processes

Binding Stability of a Cross-Linked Drug: Calculation of an Anticancer Drug Cisplatin-Dna Complex

Free energy calculations reveal the interaction and stability of ligands in the vicinity of B-DNA dodecamer

Theoretical studies on interaction of anticancer drugs (dacarbazine, procarbazine and triethylenemelamine) with normal (AT and GC) and mismatch (GG, CC, AA and TT) base pairs

Crystallographic and molecular mechanics calculations on the anti-tumor drugs N-[(2-dimethylamino)ethyl]-and N-[(2-dimethyl-amino)butyl]-9-aminoacridine-4-carboxamides and their dications: implications for models of DNA-binding

Hydrogen Bonding and Structural Characteristics of Aqueous Solution of Adriamycin

Insight into the Selective Binding Mechanism of DNMT1 and DNMT3A Inhibitors: a Molecular Simulation Study.

Unveiling the multifaceted interactions of antitumor drug mitoxantrone with ct-DNA through biophysical and in silico studies

Studying the Effects and Competitive Mechanisms of YOYO-1 on the Binding Characteristics of DOX and DNA Molecules Based on Surface-Enhanced Raman Spectroscopy and Molecular Docking Techniques

Conformational Deformations Triggered in B-DNA Dodecamer due to Major & Minor Groove Binders: Insights from QM & QM/MM Calculations

Interactions Between Dna And The Acridine Intercalator: A Computational Study